Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis

Nature Clinical Practice. Rheumatology
Marcia L MossRaphael Nudelman

Abstract

The success of agents that inhibit tumor necrosis factor (TNF), such as infliximab, adalimumab and etanercept, has led to a desire for orally available small molecules that have a better safety profile and are less costly to produce than current agents. One target for anti-TNF therapy that is currently under investigation is TNF-converting enzyme, which promotes the release of soluble TNF from its membrane-bound precursor. Inhibitors of this enzyme with drug-like properties have been made and tested in the clinic. These inhibitors include TMI-005 and BMS-561392, both of which have entered into phase II clinical trials. This article summarizes preclinical and clinical findings regarding the use of inhibitors of TNF-converting enzyme for the treatment of rheumatoid arthritis.

References

Jan 1, 1996·Annual Review of Immunology·M FeldmannR N Maini
Jul 23, 1999·Annals of the New York Academy of Sciences·A H DrummondA Wright
Apr 25, 2000·Annual Review of Medicine·K A Papadakis, S R Targan
Nov 21, 2000·Molecular and Cellular Neurosciences·J C MonteroA Pandiella
Oct 13, 2001·The New England Journal of Medicine·J KeaneM M Braun
Nov 16, 2001·Journal of Medicinal Chemistry·M H RabinowitzM C Rizzolio
Feb 2, 2002·The Journal of Biological Chemistry·Susan Wohler SunnarborgDavid C Lee
Nov 21, 2002·The Journal of Biological Chemistry·Amantha ThathiahDaniel D Carson
Apr 15, 2003·Toxicology and Applied Pharmacology·Vishal S VaidyaHarihara M Mehendale
Jun 18, 2003·The Journal of Biological Chemistry·Cécile ContinJulie Déchanet-Merville
Jun 20, 2003·Annals of the New York Academy of Sciences·David C LeeLeslie F Jackson
Sep 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Matt X G ShaoJay A Nadel
Oct 30, 2003·The Cochrane Database of Systematic Reviews·B BlumenauerG Wells
Feb 26, 2004·The Journal of Biological Chemistry·Matthew J LudemanShaun R Coughlin
Mar 3, 2004·The Journal of Cell Biology·Umut SahinCarl P Blobel
Jun 9, 2004·Biochemistry·Marcia L Moss, Jörg W Bartsch
Sep 1, 2004·The Journal of Biological Chemistry·Beatrix SchäferAxel Ullrich
Feb 5, 2005·The Journal of Biological Chemistry·Tamer RabieBernhard Nieswandt
Apr 19, 2005·Expert Opinion on Biological Therapy·Robin C Geletka, E William St Clair
Jul 16, 2005·The Journal of Biological Chemistry·Elena P ZiminaClaus-Werner Franzke
Jul 22, 2005·The Cochrane Database of Systematic Reviews·F Navarro-SarabiaI Villanueva
Aug 17, 2005·Combinatorial Chemistry & High Throughput Screening·Millard H LambertMarcia L Moss
Mar 15, 2006·The Journal of Biological Chemistry·Christopher BöhmWolfgang Hampe
Jun 14, 2006·American Journal of Physiology. Cell Physiology·Haruhiko OhtsuSatoru Eguchi

❮ Previous
Next ❯

Citations

Mar 15, 2011·Digestive Diseases and Sciences·Manabu OkawadaDaniel H Teitelbaum
Dec 30, 2010·Journal of Medicinal Chemistry·Jennifer A JacobsenSeth M Cohen
Jun 15, 2011·Nature Neuroscience·Rosa La MarcaCarla Taveggia
Nov 14, 2008·Nature Reviews. Cancer·Gillian Murphy
Jan 22, 2009·Médecine sciences : M/S·Franck PeirettiGilles Nalbone
Mar 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Christopher J TapeGillian Murphy
Jul 7, 2010·The Journal of Experimental Medicine·Athena ChalarisStefan Rose-John
May 18, 2013·Rheumatology·Emily S CollinsOliver Fitzgerald
Oct 19, 2011·The Journal of Clinical Investigation·Ricky CheungRobert H Pierce
Jan 26, 2013·The Journal of Clinical Investigation·Stefan F Lichtenthaler
Nov 1, 2013·BMC Gastroenterology·Halka BuryovaRadislav Sedlacek
Sep 13, 2011·Clinical Proteomics·Michael J DuffyPatricia M McGowan
Oct 18, 2008·Journal of Neuroinflammation·Melissa K McCoy, Malú G Tansey
Aug 2, 2012·Nutrients·Michael L McCaskillTodd A Wyatt
Dec 12, 2013·Seminars in Immunology·Jürgen SchellerStefan Rose-John
Feb 19, 2014·Analytical Biochemistry·Alexander KotzschJens Berthelsen
Sep 24, 2009·Current Rheumatology Reports·Melissa MaversHarris Perlman
Aug 3, 2012·Current Rheumatology Reports·Jun LiJohn D Mountz
Aug 14, 2015·International Journal of Molecular Sciences·Boel De Paepe, Jana Zschüntzsch
Dec 13, 2012·Expert Opinion on Drug Discovery·Prashant R MurumkarMange Ram Yadav
Feb 27, 2010·Critical Reviews in Biochemistry and Molecular Biology·Monika Gooz
Dec 15, 2015·The Journal of Pharmacology and Experimental Therapeutics·Rink-Jan LohmanDavid P Fairlie
Oct 18, 2011·Clinical Biochemistry·Roopali RoyMarsha A Moses
Nov 14, 2015·Annual Review of Pharmacology and Toxicology·Steven J ForresterSatoru Eguchi
Jul 15, 2011·Trends in Immunology·Jürgen SchellerStefan Rose-John
Sep 4, 2010·Progress in Retinal and Eye Research·Tarnjit K KheraLindsay B Nicholson
Dec 18, 2015·BBA Clinical·Henrique Neves, Hang Fai Kwok
Dec 1, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Akihiko BanYoshiki Nishizawa
May 2, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Michael J DuffyPatricia M McGowan
Sep 16, 2009·Scandinavian Journal of Immunology·Astrid WiensMichel Fleith Otuki
Mar 6, 2012·Chemical Biology & Drug Design·Torsten LingottThomas Steinbrecher
May 22, 2010·Chemical Biology & Drug Design·Malkeet S Bahia, Om Silakari

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.